Results
Aurobindo Pharma Q2FY27 Net Profit Rises 32.5% YoY
Aurobindo Pharma reported Q2FY27 unaudited results with record revenue of ₹10,263 Cr, up 23.9% YoY, and net profit of ₹1,124 Cr, up 32.5% YoY.
The company completed the acquisition of Lannett, strengt
